This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 4 - 8, 2022
Marriott Marquis San DiegoDelivered as a Hybrid Event

Raiees Andrabi, PhD
Institute Investigator, Department of Immunology and Microbiology at The Scripps Research Institute


Raiees Andrabi is an Institute Investigator in the Department of Immunology and Microbiology at The Scripps Research Institute. A major focus in his laboratory is to utilize in vitro directed evolution platform coupled with structure-guided design approaches to develop vaccine immunogens against complex pathogens such as HIV and coronaviruses. The other major area of research in his laboratory is to understand the immunological basis of B cell affinity maturation pathways to complex antigen surfaces, both in vaccination and in infection and to utilize this information for designing robust vaccines. The overall goal is to design vaccine immunogens and immunization strategies that can induce protective broadly neutralizing antibody responses against complex pathogens through vaccination in humans. Raiees Andrabi earned his PhD degree from the All India Institute of Medical Sciences in Biochemistry and performed his postdoctoral work in Dennis Burton’s laboratory at The Scripps Research Institute.

Agenda Sessions

  • From Panels of SARS-CoV-2 Broadly Neutralizing Antibodies Toward Pan-coronavirus Vaccines